NCOA2 and breast cancer: Furthermore, WB analysis confirmed that when NCOA2 was depleted in breast cancer cells, the activity of the MAPK/ERK signaling was strongly inhibited, as represented by the decreased protein levels of p-MEK and p-ERK (Figure 4C).